# Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

> **NCT00800137** · PHASE4 · TERMINATED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 984 (actual)

## Conditions studied

- Hematoma

## Interventions

- **DRUG:** low molecular weight heparin or unfractionated heparin
- **DRUG:** Warfarin or coumadin

## Key facts

- **NCT ID:** NCT00800137
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 984 (ACTUAL)
- **Why stopped:** At time of pre-specified 2nd interim analysis
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800137, "Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00800137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*